Efficacy and safety of intravenous ferric carboxymaltose in iron deficiency anemia; Real-life data from Turkey, a single center experience
The most common reason of anemia is iron deficiency. Oral iron preparations are the first and most preferred method of treatment of iron deficiency anemia (IDA). In cases where Hb levels need to be increased rapidly, intravenous iron treatment gives more favorable results. Ferric carboxymaltose (FCM...
Main Authors: | Ali Eser, Nang Hseng Kyio |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Turaz Bilim
2021-06-01
|
Series: | Medicine Science |
Subjects: | |
Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=53112 |
Similar Items
-
Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials
by: Amreen Naqash, et al.
Published: (2018-01-01) -
Iron deficiency anemia with menorrhagia: Ferric carboxymaltose a safer alternative to blood transfusion
by: Vineet Mishra, et al.
Published: (2018-01-01) -
Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia
by: Burak Yasin Aktaş, et al.
Published: (2023-11-01) -
A comparative study of ferric carboxymaltose and iron sucrose as a parenteral iron treatment in iron deficiency anemia during pregnancy in a tertiary care hospital
by: Sandip Kumar Ghosh, et al.
Published: (2024-04-01) -
Cost-minimization analysis in iron-deficiency anemia comparing intravenous ferric carboxymaltose to standard of care in pregnant women in Algeria
by: Lama Aladham, et al.
Published: (2023-01-01)